Attempted Suicide

Attempted suicide refers to a deliberate act of self-harm carried out with at least some intent to end one's life. ^[1] This complex behavior is a significant public health concern globally, associated with substantial morbidity and mortality. It is a strong risk factor for completed suicide and often co-occurs with various psychiatric disorders, including major depressive disorder (MDD), bipolar disorder (BIP), and schizophrenia (SCZ). ^[1] However, studies also indicate that genetic factors may contribute to suicide attempt risk independently of a specific psychiatric diagnosis. ^[2]

Biological Basis

Research indicates a significant biological component to attempted suicide. Studies have identified significant SNP-based heritability for attempted suicide, with estimates around 4%, suggesting a polygenic architecture where many common genetic variants each contribute small effects to overall risk. ^[1] Initial genome-wide association studies (GWAS) were often underpowered to detect these subtle genetic influences, but larger cohorts are now yielding more definitive findings. ^[1]

Specific genetic loci have been associated with attempted suicide. For instance, a meta-analysis identified rs300774 on chromosome 2p25 as approaching genome-wide significance. ^[3] More recently, GWAS in individuals with psychiatric disorders identified rs45593736 within the ARL5B gene as genome-wide significant in MDD patients, and an insertion-deletion polymorphism (chr4_23273116_D) on chromosome 4 in BIP patients. ^[1] Other studies have reported variants like rs12972617 and rs12972618 on chromosomes 5 and 19 ^[2] and rs11762112 (intergenic on chromosome 7) and rs79324256 in the KCNMB2 gene on chromosome 3. ^[4] The use of polygenic risk scores (PRS) has also shown modest predictive ability for suicide attempt, further supporting its polygenic nature. ^[1]

Clinical Relevance

The clinical significance of understanding the genetics of attempted suicide is profound. Identifying genetic predispositions can help clinicians better assess individual risk, particularly in patients with psychiatric disorders, where the proportion of those reporting suicide attempts can range from 16% in MDD to 36–37% in bipolar disorder and schizophrenia. ^[1] Genetic insights may also help differentiate between suicidal ideation and actual suicide attempts, as distinct genetic and environmental factors may underlie these behaviors. ^[4] Ultimately, a deeper understanding of the genetic architecture can inform targeted prevention strategies and personalized interventions for individuals at high risk.

Attempted suicide represents a major public health challenge, impacting individuals, families, and communities. The development of large-scale genetic studies, such as those utilizing the UK Biobank, allows for the investigation of genetic factors at a population level. ^[2] By elucidating the genetic underpinnings, research contributes to reducing the societal burden of suicidal behaviors. This knowledge is crucial for developing more effective screening tools, preventative measures, and improved treatment approaches, thereby enhancing public mental health outcomes.

Methodological and Statistical Power Limitations

Genetic studies of suicide attempt, even large-scale meta-analyses, face challenges related to statistical power. Sample sizes, while growing, are often insufficient to robustly detect the small genetic effects typically associated with single nucleotide polymorphisms (SNPs), especially considering that SNP-heritability estimates for suicide attempt are generally much lower than those derived from twin studies. ^[1]

Despite efforts to identify genome-wide significant loci, some findings have not consistently replicated at nominal significance in independent cohorts, underscoring the need for more stringent validation across diverse studies. ^[2]

Phenotypic Heterogeneity and Ascertainment Challenges

The definition of suicide attempt in genetic studies often relies on a broad "lifetime suicide attempt" criterion to maximize sample size, which inherently limits the granularity of the phenotype. This broad definition typically lacks detailed information regarding the severity of attempts, the number of attempts, associated medical consequences, or specific methods used. ^[1]

Data collection methods, especially when utilizing electronic medical records, can introduce confounding factors. For instance, the prevalence of diagnosed disorders can be confounded by age, and the likelihood of missing diagnoses may vary across different periods of assessment. ^[5]

Ancestral Diversity and Generalizability

A significant limitation in current genetic studies of suicide attempt is the insufficient ancestral diversity within study cohorts, with a predominant focus on individuals of European ancestry. ^[5]

The limited ancestral diversity directly impacts the portability of polygenic risk scores and the generalizability of identified genetic risk signals, highlighting a critical need for broader representation across global populations. Expanding research efforts to include more diverse ancestral groups, particularly from population-dense regions such as India, West Asia, and the Global South, is essential to enhance the rigor and applicability of GWAS results for suicide phenotypes. ^[6]

Variants

Genetic variants play a significant role in an individual's susceptibility to attempted suicide, influencing various neurobiological pathways related to mood regulation, impulse control, and stress response. Genome-wide association studies (GWAS) and meta-analyses have identified several specific single nucleotide polymorphisms (SNPs) and their associated genes that contribute to this complex trait. These variants often affect genes involved in neurotransmission, synaptic function, and gene expression regulation, providing insights into the biological underpinnings of suicidal behavior.

Several variants influencing neurotransmitter systems and neuronal excitability have been linked to suicide attempts. The DRD2 gene, encoding the D2 dopamine receptor, is crucial for reward processing, motivation, and impulse control, with its variant rs7131627 identified in a meta-analysis of suicide attempt . For instance, some studies utilize specific questions from structured interviews, such as the SCAN interview, to identify instances of self-harm or suicide attempts that resulted in serious harm or were critically intended to be lethal. ^[7] Operational definitions in large-scale studies frequently leverage diverse data sources, including International Classification of Diseases (ICD-9/ICD-10) codes for self-injury, specialized reports like those from the Suicide Prevention Applications Network (SPAN) database, and direct self-reported histories from mental health surveys. ^[4] This multi-faceted approach aims to comprehensively capture instances of attempted suicide within heterogeneous populations.

It is crucial to differentiate attempted suicide from suicidal ideation, which refers to thoughts of suicide without a corresponding physical act. Research studies often explicitly exclude individuals with suicidal ideation but no history of attempts from control groups to maintain phenotypic specificity and reduce heterogeneity, thereby enhancing the power to detect genetic associations. ^[4] Conceptually, attempted suicide is understood to have a polygenic architecture, indicating that multiple genes with small effects contribute to the overall genetic liability, often in interaction with environmental stressors. ^[1] This framework guides genetic investigations into the underlying biological mechanisms of suicidal behavior.

Key Variants

RS ID	Gene	Related Traits
rs6907713	MIR3144 - RNU6-214P	attempted suicide
rs62474683	LINC01392 - POLR2DP2	attempted suicide
rs7131627	DRD2	attempted suicide mathematical ability
rs3791129	SLC6A9	attempted suicide
rs17514846	FURIN	coronary artery disease parental longevity mean arterial pressure systolic blood pressure hypertension
rs62404522	LNC-LBCS	attempted suicide
rs9525171	HS6ST3	attempted suicide
rs850261	OTX2-AS1	attempted suicide
rs7649709	NLGN1	attempted suicide
rs2284000	CACNG2	attempted suicide

Classification and Severity Assessment

The classification of attempted suicide often navigates between categorical and dimensional approaches, with growing recognition of the spectrum of suicidal behavior. While traditional case-control studies categorize individuals as "attempters" or "non-attempters," this binary classification may oversimplify the complex nature of suicidal acts and potentially limit statistical power by not reflecting the true range of severity. ^[8] Consequently, investigations increasingly focus on quantitative measures and severity gradations to better capture the nuances of attempts, considering factors such as the degree of aggression, violence, or potential lethality involved. ^[9] This allows for a more detailed understanding beyond a simple present/absent dichotomy.

Severity assessment scales, such as adaptations derived from instruments like the Suicide Intent Scale (SIS) or the SCAN Suicide Severity item, aim to quantify the intensity and potential harm of an attempt. For example, the SCAN item categorizes attempts on a scale from deliberately considering self-harm to attempts designed to be lethal, while other scales score severity based on objective outcomes like the need for medical treatment or hospitalization. ^[8] Modern tools like the Columbia-Suicide Severity Rating Scale (C-SSRS) are designed to distinguish various domains of suicidal ideation and behavior, reflecting evidence that distinct subtypes are present within suicidal behavior. ^[8] This dimensional approach helps reduce sample heterogeneity in research and allows for a more granular understanding of risk factors.

Terminology and Measurement Approaches

The terminology surrounding self-directed harmful acts is precise within clinical and research contexts, with "suicide attempt" being the primary focus for studies examining the act itself. Related concepts include "suicidal ideation" for thoughts of suicide and the broader term "suicidal behavior," which encompasses a range of actions from ideation to completed suicide. ^[8] Research studies commonly classify participants into "attempters" and "non-attempters" based on their lifetime history of such behaviors, often through self-report or retrospective data collection. ^[3] These classifications are fundamental for genetic association studies comparing affected and unaffected individuals.

Measurement approaches for identifying attempted suicide are varied and include structured clinical interviews like the SCAN interview, which assesses self-injury or attempts designed to result in death. ^[7] Additionally, electronic health record (EHR) data, incorporating diagnostic codes (e.g., ICD-9/ICD-10 self-injury codes), and mental health survey responses are increasingly utilized for large-scale phenotyping. ^[2] However, retrospective assessment methods, particularly those relying on a limited number of items, carry the risk of underreporting and misclassification error, which can diminish the power to detect genetic associations and lead to an incomplete understanding of the trait. ^[9] The development of machine learning-derived phenotyping algorithms from clinical EHR data represents an evolving approach to more accurately quantify the predicted probability of attempting suicide. ^[2]

Causes of Attempted Suicide

Attempted suicide is a complex behavior influenced by a multifaceted interplay of genetic, environmental, developmental, and clinical factors. Research indicates that while psychiatric disorders are highly prevalent among individuals who attempt suicide, a distinct genetic predisposition also contributes to this behavior, often interacting with environmental stressors.

Genetic Susceptibility and Polygenic Architecture

Twin and family studies consistently demonstrate a significant genetic component to suicidal behavior, with heritability estimates ranging from 30% to 55%. This genetic predisposition is considered partially independent of the inheritance of psychiatric disorders themselves, suggesting a specific vulnerability to suicidal acts. ^[10] The genetic architecture of attempted suicide is largely polygenic, meaning it involves the cumulative effect of many common genetic variants, each contributing a small amount of risk. Polygenic risk scores have shown modest predictive ability, and SNP-based heritability estimates for suicide attempt are typically around 4% to 4.6%. ^[2]

While robustly replicated genome-wide significant loci have been challenging to identify, several genetic variants and regions have been associated with increased risk for attempted suicide in various studies. For instance, the rs300774 variant on chromosome 2p25 has been implicated, and other studies have pointed to SNPs in genes like KCNMB2 on chromosome 3 (rs79324256, rs6788360, rs7861880) and LUZP2 on chromosome 11 (rs7931096). ^[11] Specific genetic associations have also been found within psychiatric disorder contexts, such as rs45593736 in the ARL5B gene for suicide attempts in major depressive disorder and an insertion-deletion polymorphism on chromosome 4 in bipolar disorder. ^[1] These findings underscore the complex genetic landscape underlying susceptibility to attempted suicide.

Environmental and Developmental Modulators

Environmental factors, particularly adverse early life experiences, play a critical role in shaping an individual's risk for attempted suicide. Factors such as parental abuse and early parental loss are recognized environmental risk factors that can significantly influence an individual's vulnerability. ^[12] These early life stressors can have lasting impacts on psychological development and coping mechanisms, potentially increasing the likelihood of suicidal behavior later in life. Additionally, broader socioeconomic conditions are considered important covariates in population-based studies of suicide attempt, indicating that external societal and economic pressures can contribute to an individual's risk profile. ^[13]

Complex Gene-Environment Interactions

The risk for attempted suicide is often best understood through a stress-diathesis model, where genetic predispositions interact with environmental triggers. An individual may possess genetic variants that confer a heightened vulnerability to suicidal behavior, but these tendencies may only manifest under specific environmental stressors. For example, genetic factors may interact with environmental risk factors like parental abuse or early parental loss, collectively increasing the overall risk for suicidal behavior. ^[12] Similarly, psychiatric illnesses or other significant life stressors can aggravate an individual’s underlying genetic susceptibility, leading to the manifestation of suicidal ideation and attempts. ^[10] This intricate interplay highlights that neither genes nor environment alone fully account for the risk, but rather their synergistic effects.

Clinical Comorbidities and Associated Factors

A substantial majority of individuals who attempt suicide, often exceeding 90%, have a diagnosable psychiatric disorder. ^[1] Mood disorders, such as major depression and bipolar disorder, along with schizophrenia and substance use disorders, are particularly common comorbidities. While mental disorders and suicidality are often clinically intertwined, with suicidal ideation sometimes being a diagnostic criterion for depression, research suggests that the genetic underpinnings of suicide attempt are partially distinct from those of the comorbid psychiatric disorders themselves. ^[1] Furthermore, demographic factors such as sex can also be associated with attempted suicide, with a higher proportion of females observed among attempters within psychiatric cohorts. ^[1]

Biological Background of Attempted Suicide

Attempted suicide is a complex behavior influenced by a multifaceted interplay of biological factors, including genetic predispositions, neurochemical imbalances, and disruptions in key molecular and cellular pathways. Research indicates a significant biological component that operates independently of, but can be aggravated by, psychiatric disorders and environmental stressors. Understanding these underlying biological mechanisms is crucial for elucidating the pathophysiology of suicidal behavior.

Neurotransmitter Dysregulation and Molecular Signaling

Dysregulation of neurotransmitter systems, particularly the serotonergic system, is a prominent biological correlate of attempted suicide. Studies have consistently observed decreased levels of 5-hydroxyindolacetic acid (5-HIAA), a primary metabolite of serotonin, in the cerebrospinal fluid of individuals who have attempted suicide. ^[12] This reduction suggests impaired serotonin function, a key neurotransmitter involved in mood regulation, impulse control, and emotional processing. Genes critical to serotonin metabolism, such as tryptophan hydroxylase genes (TPH1 and TPH2) responsible for serotonin synthesis, and the serotonin transporter gene (SLC6A4) involved in its reuptake, are key biomolecules whose functions directly impact the availability and signaling of serotonin in the brain. ^[12] Disruptions in these molecular and cellular pathways can lead to an imbalance in brain homeostasis, contributing to the neurobiological underpinnings of suicidal behavior.

Beyond serotonin, other neurotransmitter and signaling pathways are also implicated. Molecular pathway analyses have revealed significant enrichment in pathways related to postsynaptic signaling, general neurotransmission, and neurodevelopment in suicide-related phenotypes. ^[14] Specifically, NOTCH signaling and gamma-aminobutyric acid (GABA)-ergic signaling pathways have been associated with particular suicide-related phenotypes, highlighting their roles in neuronal communication and circuit development. ^[14] The enzyme COMT (Catechol-O-methyltransferase), through its associated variant rs4680, is involved in the metabolism of catecholamine neurotransmitters like dopamine and norepinephrine, further contributing to the intricate network of neurochemical regulation that can be disrupted in individuals at risk for attempted suicide. ^[15] These widespread disruptions collectively impact brain function at the tissue and organ level, influencing mood, cognition, and behavioral control.

Genetic Architecture and Gene-Environment Interactions

A significant genetic component underlies suicidal behavior, recognized through twin, family, and adoption studies that show elevated rates of suicide attempts among relatives even after accounting for psychiatric disorders. ^[10] This suggests a distinct genetic predisposition, which is often conceptualized within a stress-diathesis model where psychiatric illnesses or other life stressors can aggravate an individual's inherent genetic vulnerability. ^[10] Attempted suicide is characterized by a polygenic architecture, meaning that many genes with small individual effects collectively contribute to the trait, resulting in modest but significant SNP-heritability estimates. ^[1] While genome-wide association studies (GWAS) have faced challenges in identifying robust genome-wide significant loci, likely due to the complex nature and small effect sizes of individual genetic variants, several genes have emerged as potential contributors.

Specific genetic findings from GWAS include the identification of rs300774 near the ACP1 (Acid Phosphatase 1) gene, which has shown genome-wide significance and subsequent replication. ^[12] Another SNP, rs45593736 in an intron of the ARL5B (ADP-Ribosylation Factor-Like 5B) gene, reached genome-wide significance in a GWAS of suicide attempt in major depressive disorder patients. ^[1] Additionally, a variant in the PDE4B (Phosphodiesterase-4B) gene on chromosome 1p31.3 has been associated with suicide attempts, with studies in mice showing that deficiency in PDE4B can lead to anxiogenic-like behavioral phenotypes. ^[13] These genetic mechanisms, through their influence on gene expression patterns and cellular functions, contribute to the underlying pathophysiological processes that increase an individual's susceptibility to suicidal behavior, particularly when interacting with environmental risk factors such as early parental loss or abuse. ^[12]

Neurodevelopment, Neurotrophic Factors, and Stress Response

Neurodevelopmental processes and the response to stress are critical biological domains linked to attempted suicide. Brain-derived neurotrophic factor (BDNF), a key biomolecule, plays a vital role in neuronal survival, growth, differentiation, and synaptic plasticity, which are fundamental to healthy neurodevelopment and brain function. Genetic variations, such as the BDNF rs6265 Met66 allele, have been associated with suicide attempts, suggesting that alterations in BDNF signaling can impact neuronal resilience and contribute to vulnerability. ^[15] Its receptor, NTRK2 (Neurotrophic Receptor Tyrosine Kinase 2), is also increasingly recognized for its role in this pathway, further underscoring the importance of neurotrophic support in mitigating risk. ^[15] Disruptions in these neurotrophic pathways can impair the brain's ability to adapt and recover from stress, contributing to developmental vulnerabilities.

The body's stress response system, primarily mediated by the hypothalamic-pituitary-adrenal (HPA) axis, is also a critical area of investigation. Key biomolecules involved in stress regulation include FKBP5 (FK506 binding protein 5) and CRHR1 (Corticotropin-releasing Hormone Receptor 1). Specific single nucleotide polymorphisms (SNPs) in these genes, such as FKBP5 rs3800373 and rs1360780, and CRHR1 rs2664008, rs1724425, and rs878886, have been linked to suicidal behavior. ^[15] These proteins are integral to the molecular and cellular pathways that regulate glucocorticoid receptor sensitivity and the release of stress hormones. Dysregulation within these pathways can lead to an exaggerated or prolonged stress response, disrupting homeostatic mechanisms and rendering individuals more susceptible to the pathophysiological consequences of chronic stress, thereby increasing the risk for suicidal ideation and attempts.

Metabolic Pathways and Cellular Function

Beyond neurotransmission and stress, specific metabolic processes and cellular functions also contribute to the biological landscape of attempted suicide. The gene ACP1 (Acid Phosphatase 1), implicated by the rs300774 variant, has been associated with brain cholesterol biosynthesis. ^[11] Cholesterol is a crucial structural component of neuronal membranes and plays a vital role in synaptic function, neurotransmitter release, and signal transduction. Alterations in brain cholesterol metabolism, therefore, can have profound impacts on overall neuronal health and communication at the cellular level, potentially affecting the regulatory networks underlying mood and behavior.

Another significant metabolic pathway involves polyamine catabolism, where the enzyme SSAT (Spermidine/Spermine N1-acetyltransferase) acts as the rate-limiting enzyme. Microarray expression studies have implicated SSAT as a candidate gene for suicidal behavior. ^[12] Polyamines are essential organic cations involved in fundamental cellular processes such as cell growth, differentiation, and gene expression. Dysregulation in polyamine metabolism can affect various cellular functions and regulatory networks within the brain, potentially leading to systemic consequences that compromise neuronal integrity and function. These metabolic disruptions highlight how fundamental cellular processes, when altered, can contribute to the complex biological vulnerability for attempted suicide.

Population Studies of Attempted Suicide

Population studies of attempted suicide leverage large datasets and diverse methodologies to understand its prevalence, underlying risk factors, and genetic architecture. These investigations provide critical insights into demographic patterns, the influence of psychiatric comorbidities, and the biological underpinnings of this complex behavior, while also highlighting the methodological challenges inherent in its study.

Epidemiological Patterns and Demographic Correlates

Research across various cohorts has elucidated key epidemiological patterns and demographic factors associated with attempted suicide. The prevalence of attempted suicide varies significantly across different psychiatric disorders, with studies reporting 16% in individuals with Major Depressive Disorder (MDD) and higher proportions, ranging from 36% to 37%, in those diagnosed with bipolar disorder and schizophrenia. ^[1] Globally, estimates suggest that suicide attempts occur 10 to 25 times more frequently than deaths by suicide, with a lifetime prevalence of suicidal ideation affecting 6% to 14% of the population. ^[2] Furthermore, demographic analyses reveal consistent trends, such as a higher proportion of females among suicide attempters compared to non-attempters across MDD, bipolar disorder, and schizophrenia cohorts. ^[1] Age-specific studies, such as those focusing on individuals under 32 years, indicate that findings often pertain to age segments with the highest rates of attempted suicide. ^[13]

Large-Scale Cohort Investigations and Genetic Insights

Large-scale cohort studies, including those utilizing biobanks and extensive clinical datasets, have been instrumental in advancing the understanding of attempted suicide, particularly in uncovering its genetic architecture. Major population cohorts like the UK Biobank, the Psychiatric Genomics Consortium (PGC), and the Danish iPSYCH cohort have provided robust platforms for genome-wide association studies (GWAS). ^[2] These studies involve tens to hundreds of thousands of individuals, enabling the identification of genetic factors associated with attempted suicide. For instance, specific genetic variants, such as rs45593736 within the ARL5B gene for attempted suicide in MDD and an insertion-deletion polymorphism on chromosome 4 for attempted suicide in bipolar disorder, have reached genome-wide significance. ^[1] Furthermore, twin studies suggest that while the heritability of suicidal ideation may largely be accounted for by the familial transmission of disease liability, the risk for suicidal behavior itself exhibits a distinct and significant heritable component. ^[9] These findings are reinforced by analyses demonstrating significant SNP-based heritability for attempted suicide and substantial genetic correlations with other psychiatric disorders and conditions like insomnia. ^[2]

Cross-Population Comparisons and Methodological Considerations

Cross-population studies have begun to explore ancestry-specific and pan-ancestry genetic risk factors for attempted suicide, while also highlighting critical methodological considerations in data collection and analysis. Cohorts from diverse ancestral backgrounds, including European, admixed African American, and East Asian ancestries, are being analyzed to identify both shared and population-specific genetic loci. ^[1] Methodologies for ascertaining attempted suicide phenotypes vary, encompassing structured psychiatric interviews, self-report questionnaires, hospital records, and International Classification of Diseases (ICD) codes, sometimes augmented by machine learning algorithms applied to electronic health records. ^[1] However, these diverse approaches introduce limitations, such as potential misclassification due to underreporting of past attempts or the possibility that individuals classified as non-attempters may attempt suicide later. ^[9] The representativeness and generalizability of findings are also influenced by factors like the age range of the study population, the specific inclusion/exclusion criteria for controls, and the inherent challenges in accurately capturing a behavior that is often under-recorded in clinical settings. ^[13]

Ethical Considerations in Genetic Information and Privacy

Research into the genetic underpinnings of suicide attempt involves highly sensitive personal information, necessitating rigorous ethical standards for data collection and utilization. Studies often leverage large-scale population samples with extensive phenotypic and genetic data, such as those from the UK Biobank, or de-identified electronic health records. ^[2] Ensuring genuinely informed consent is paramount, especially when participants provide genetic data and disclose deeply personal experiences like suicide attempts, given the profound implications this information can have for their lives. ^[1] The inherently sensitive nature of this data demands clear communication about its potential uses, the inherent risks, and the ongoing right to privacy.

The identification of genetic variants or polygenic risk scores associated with suicide attempt raises significant concerns about potential genetic discrimination. If such genetic predispositions become public knowledge, individuals could face unfair treatment in various domains, including employment, insurance, or social contexts, thereby exacerbating existing societal biases against those with mental health challenges. ^[9] To mitigate these risks, robust data protection measures and strict regulatory frameworks are essential to safeguard genetic information and prevent its misuse, ensuring that advancements in understanding the biological basis of suicide attempt do not inadvertently harm vulnerable individuals.

Suicide attempt carries immense social stigma, which could be further complicated by the discovery of genetic predispositions. While genetic insights might offer a biological explanation that reduces self-blame, they could also lead to new forms of labeling or societal judgment, influencing how individuals are perceived and treated. ^[8] This persistent stigma profoundly impacts help-seeking behaviors, often deterring individuals from accessing necessary mental health support and perpetuating a cycle of silence and isolation around suicidal ideation and attempts. Addressing this requires comprehensive public education and anti-stigma campaigns that integrate genetic understanding thoughtfully.

Existing health disparities and inequities in access to mental healthcare are critical social implications that must be addressed in conjunction with genetic research. Socioeconomic factors, cultural considerations, and geographic location significantly influence both the risk of suicide attempt and the availability of adequate treatment and support services. ^[16] For vulnerable populations, including those from diverse ancestries and lower socioeconomic backgrounds, achieving health equity necessitates not only equitable access to genetic testing and counseling but also fair resource allocation for comprehensive mental health services that are culturally competent, accessible, and integrated into broader healthcare systems.

Policy, Regulation, and Responsible Application

The development of genetic tests or predictive models for suicide attempt risk, such as those utilizing machine learning with high accuracy from electronic health record data, necessitates stringent policy and regulatory frameworks. ^[2] These regulations must govern the ethical conduct of genetic research, ensure the validity and clinical utility of any diagnostic or prognostic applications, and establish clear guidelines for how such sensitive genetic information is communicated to individuals and integrated into clinical practice. This includes defining appropriate uses, preventing misinterpretation, and ensuring that interventions are supportive and empowering rather than punitive.

Research ethics are paramount in studies involving suicide attempt, given the vulnerability of participants and the potential for distress. Ethical guidelines must ensure participant safety, confidentiality, and the responsible dissemination of findings, particularly when dealing with underreported phenotypes and the complexities of assessing suicidal intent. ^[9] While not explicitly detailed in the provided context, the broader ethical discussions around genetic information often include reproductive choices; thus, any future implications of genetic findings for suicide attempt on family planning would require careful consideration of informed decision-making, individual autonomy, and a commitment to avoiding eugenics.

Frequently Asked Questions About Attempted Suicide

These questions address the most important and specific aspects of attempted suicide based on current genetic research.

1. My sibling struggled with this; does that mean I will too?

Not necessarily, but you might share some genetic predispositions. Research shows that about 4% of the risk for attempted suicide is due to common genetic variations, indicating a polygenic architecture where many genes each contribute a small effect. While you share genes with your sibling, your unique combination of genetic factors and life experiences means your personal risk isn't identical. Understanding family history is important, but it's not a direct prediction.

2. I don't have a mental illness diagnosis; am I still at risk?

Yes, it's possible. While attempted suicide often co-occurs with psychiatric disorders like major depressive disorder or bipolar disorder, studies also indicate that genetic factors can contribute to your risk independently of a specific psychiatric diagnosis. This means that even without a formal diagnosis, genetic predispositions could play a role in an individual's vulnerability.

3. Does everyday stress activate my genetic risk?

While the precise mechanisms are complex, research highlights that distinct genetic and environmental factors underlie suicidal behaviors. This means your genetic predispositions interact with your life experiences and environment, including stress, which can influence your overall risk. Understanding this complex interplay is key to personalized prevention strategies.

4. Could a DNA test predict my personal risk for this?

Current DNA tests using polygenic risk scores (PRS) have shown modest predictive ability for suicide attempt. While they can identify some genetic predispositions, the current understanding of the polygenic architecture means they are not yet definitive diagnostic tools. Larger studies are continually improving our ability to identify these subtle genetic influences and refine risk prediction.

5. Why do some struggle with this, but I don't, with similar problems?

This difference often comes down to individual genetic variations and unique life experiences. Attempted suicide is polygenic, meaning many common genetic variants, like those within the ARL5B or KCNMB2 genes, each contribute small effects to overall risk. Even with similar life circumstances, your specific combination of these genetic factors can make your vulnerability different from someone else's.

6. Can knowing my genetic risks help prevent future attempts?

Yes, a deeper understanding of your genetic architecture can be incredibly valuable. Identifying genetic predispositions can help clinicians better assess your individual risk, especially if you have psychiatric disorders. This insight can inform targeted prevention strategies and personalized interventions, potentially leading to more effective support and improved mental health outcomes.

7. Does the severity of an attempt matter genetically?

Research currently uses a broad "lifetime suicide attempt" definition, which often lacks detailed information about severity, number of attempts, or specific methods. This broad approach can obscure genetic signals that might be specific to more severe or repeated attempts. Future studies with more detailed phenotypic data are needed to fully understand if severity has distinct genetic underpinnings.

8. Does my ethnic background affect my risk for this?

While genetic correlations between different populations (like civilian and military cohorts) have often shown consistency, differences in how studies recruit participants could introduce subtle biases. Large-scale genetic studies, such as those utilizing resources like the UK Biobank, are crucial for investigating factors at a population level and ensuring that genetic insights are broadly applicable and relevant across diverse backgrounds.

9. If I have depression, am I guaranteed to attempt suicide?

Absolutely not. While major depressive disorder is a strong risk factor, only a proportion of individuals with MDD, around 16%, report suicide attempts. Attempted suicide is a complex behavior influenced by many factors, including polygenic risk and environmental influences, so a diagnosis increases vigilance but does not guarantee an attempt.

10. Is just thinking about suicide genetically different from attempting it?

Yes, research suggests that suicidal ideation (thinking about suicide) and actual suicide attempts may be influenced by distinct genetic and environmental factors. While often related, the underlying biological pathways contributing to the thought process versus the act itself can differ. This distinction is important for developing more precise prevention and intervention strategies.

This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.

Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.

References

[1] Mullins, N. et al. "GWAS of Suicide Attempt in Psychiatric Disorders and Association With Major Depression Polygenic Risk Scores." Am J Psychiatry, vol. 176, no. 10, Oct. 2019, pp. 836-47.

[2] Ruderfer, D. M. et al. "Significant shared heritability underlies suicide attempt and clinically predicted probability of attempting suicide." Mol Psychiatry, vol. 24, no. 1, Jan. 2019, pp. 154-61.

[3] Willour, V. L., et al. "A genome-wide association study of attempted suicide." Mol Psychiatry, vol. 17, no. 4, 2012, pp. 385-393.

[4] Kimbrel, N. A. et al. "A genome-wide association study of attempted suicide in the million veterans program identifies evidence of pan-ancestry and ancestry-specific risk loci." Molecular Psychiatry, vol. 27, no. 6, 2022, pp. 2742-2751.

[5] Docherty, Alex R., et al. "Genome-Wide Association Study of Suicide Death and Polygenic Prediction of Clinical Antecedents." Am J Psychiatry, vol. 177, no. 12, 2020, pp. 1162-1172.

[6] Docherty, Alex R., et al. "GWAS Meta-Analysis of Suicide Attempt: Identification of 12 Genome-Wide Significant Loci and Implication of Genetic Risks for Specific Health Factors." Am J Psychiatry, vol. 180, no. 10, 2023, pp. 783-796.

[7] Schosser, A., et al. "Genome-wide association study of suicidal ideation and attempt in European samples." Mol Psychiatry, vol. 16, no. 11, 2011, pp. 1089-1096.

[8] Levey, D. F., et al. "Genetic associations with suicide attempt severity and genetic overlap with major depression." Transl Psychiatry, vol. 9, no. 1, 2019, p. 25.

[9] Perlis, R. H. et al. "Genome-wide association study of suicide attempts in mood disorder patients." American Journal of Psychiatry, vol. 167, no. 12, 2010, pp. 1499-1507.

[10] Mullins, N. "Genetic relationships between suicide attempts, suicidal ideation and major psychiatric disorders: a genome-wide association and polygenic scoring study." Am J Med Genet B Neuropsychiatr Genet, vol. 165B, no. 5, 2014, pp. 433-442.

[11] Li, J., et al. "Replication of rs300774, a genetic biomarker near ACP1, associated with suicide attempts in patients with schizophrenia: Relation to brain cholesterol biosynthesis." Journal of Psychiatric Research, vol. 94, 2017, pp. 54-61.

[12] Willour, V. L. et al. "A genome-wide association study of attempted suicide." Mol Psychiatry, vol. 16, no. 4, Apr. 2011, pp. 433-444.

[13] Erlangsen, A., et al. "Genetics of suicide attempts in individuals with and without mental disorders: a population-based genome-wide association study." Mol Psychiatry, vol. 23, no. 12, 2018, pp. 2226-2233.

[14] Lybech, L. K. M., et al. "Suicide Related Phenotypes in a Bipolar Sample: Genetic Underpinnings." Genes (Basel), vol. 12, no. 10, 2021, p. 1482.

[15] Zai, C. C., et al. "Genome-wide association study of suicidal behaviour severity in mood disorders." World J Biol Psychiatry, vol. 22, no. 8, 2021, pp. 627-638.

[16] Mullins, N. et al. "Dissecting the Shared Genetic Architecture of Suicide Attempt, Psychiatric Disorders, and Known Risk Factors." Biological Psychiatry, vol. 90, no. 11, 2021, pp. 726-736.